{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:24:08Z","timestamp":1794925448928,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]},{"name":"the Key Research and Development Program of Anhui Province","award":["2022e07020058"],"award-info":[{"award-number":["2022e07020058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-03951-y","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:05:53Z","timestamp":1778155553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SGLT2 inhibitor dapagliflozin alleviates ventricular remodeling and apoptosis after myocardial infarction by inhibiting the TGF-\u03b21 and MAPK pathways"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"Suppl 3","key":"3951_CR1","first-page":"156","volume":"35","author":"RB Jennings","year":"1974","unstructured":"Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res. 1974;35(Suppl 3):156\u201372.","journal-title":"Circ Res"},{"issue":"3","key":"3951_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/clinchem\/46.3.338","volume":"46","author":"DS Ooi","year":"2000","unstructured":"Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem. 2000;46(3):338\u201344.","journal-title":"Clin Chem"},{"issue":"18","key":"3951_CR3","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","volume":"31","author":"K Thygesen","year":"2010","unstructured":"Thygesen K, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197\u2013204.","journal-title":"Eur Heart J"},{"issue":"2","key":"3951_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1470-8744.1998.tb00519.x","volume":"28","author":"NA Morjana","year":"1998","unstructured":"Morjana NA. Degradation of human cardiac troponin I after myocardial infarction. Biotechnol Appl Biochem. 1998;28(2):105\u201311.","journal-title":"Biotechnol Appl Biochem"},{"issue":"5","key":"3951_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/cclm-2014-0475","volume":"53","author":"K Solecki","year":"2015","unstructured":"Solecki K, et al. Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction. Clin Chem Lab Med. 2015;53(5):707\u201314.","journal-title":"Clin Chem Lab Med"},{"issue":"18","key":"3951_CR6","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252\u20137.","journal-title":"Eur Heart J"},{"issue":"15","key":"3951_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.jacc.2021.02.041","volume":"77","author":"KH Cho","year":"2021","unstructured":"Cho KH, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2021;77(15):1859\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3951_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91\u2013112.","journal-title":"Circ Res"},{"issue":"22","key":"3951_CR9","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","volume":"121","author":"M Nahrendorf","year":"2010","unstructured":"Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121(22):2437\u201345.","journal-title":"Circulation"},{"issue":"11","key":"3951_CR10","doi-asserted-by":"publisher","first-page":"F889","DOI":"10.1152\/ajprenal.00267.2015","volume":"309","author":"MA Abdul-Ghani","year":"2015","unstructured":"Abdul-Ghani MA, Norton L, DeFronzo RA. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2015;309(11):F889-900.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"3951_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/jdi.12625","volume":"8","author":"X Cai","year":"2017","unstructured":"Cai X, et al. Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: a meta-analysis. J Diabetes Investig. 2017;8(4):510\u20137.","journal-title":"J Diabetes Investig"},{"key":"3951_CR12","doi-asserted-by":"crossref","unstructured":"Mazidi M, et al. Effect of sodium-glucose cotransport-2 inhibitors on blood pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43 randomized control trials with 22 528 patients. J Am Heart Assoc. 2017;6(6):e004007.","DOI":"10.1161\/JAHA.116.004007"},{"issue":"10","key":"3951_CR13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","volume":"122","author":"AJ Scheen","year":"2018","unstructured":"Scheen AJ. Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors. Circ Res. 2018;122(10):1439\u201359.","journal-title":"Circ Res"},{"issue":"10354","key":"3951_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","volume":"400","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomized controlled trials. Lancet. 2022;400(10354):757\u201367.","journal-title":"Lancet"},{"issue":"1","key":"3951_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","volume":"44","author":"J Biegus","year":"2023","unstructured":"Biegus J, et al. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J. 2023;44(1):41\u201350.","journal-title":"Eur Heart J"},{"issue":"1","key":"3951_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-020-01208-z","volume":"20","author":"D Bode","year":"2021","unstructured":"Bode D, et al. Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF. Cardiovasc Diabetol. 2021;20(1):7.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3951_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000504694","volume":"145","author":"D Santos-Ferreira","year":"2020","unstructured":"Santos-Ferreira D, Gon\u00e7alves-Teixeira P, Fontes-Carvalho R. SGLT-2 inhibitors in heart failure and type-2 diabetes: hitting two birds with one stone? Cardiology. 2020;145(5):311\u201320.","journal-title":"Cardiology"},{"issue":"1","key":"3951_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02210-5","volume":"23","author":"W Guo","year":"2024","unstructured":"Guo W, et al. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study. Cardiovasc Diabetol. 2024;23(1):118.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"3951_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022;387(12):1089\u201398.","journal-title":"N Engl J Med"},{"issue":"10254","key":"3951_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","volume":"396","author":"F Zannad","year":"2020","unstructured":"Zannad F, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020;396(10254):819\u201329.","journal-title":"Lancet"},{"issue":"14","key":"3951_CR21","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","volume":"113","author":"KC Park","year":"2017","unstructured":"Park KC, et al. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708\u201318.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3951_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","volume":"35","author":"M Schiller","year":"2004","unstructured":"Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35(2):83\u201392.","journal-title":"J Dermatol Sci"},{"issue":"6","key":"3951_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685\u2013700.","journal-title":"Cell"},{"issue":"3","key":"3951_CR24","doi-asserted-by":"publisher","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","volume":"283","author":"S Rosenkranz","year":"2002","unstructured":"Rosenkranz S, et al. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol. 2002;283(3):H1253-62.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"3951_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00395-007-0689-5","volume":"103","author":"Y Sakata","year":"2008","unstructured":"Sakata Y, et al. Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol. 2008;103(1):60\u20138.","journal-title":"Basic Res Cardiol"},{"issue":"6958","key":"3951_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature. 2003;425(6958):577\u201384.","journal-title":"Nature"},{"issue":"52","key":"3951_CR27","doi-asserted-by":"publisher","first-page":"37413","DOI":"10.1074\/jbc.274.52.37413","volume":"274","author":"ME Engel","year":"1999","unstructured":"Engel ME, et al. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem. 1999;274(52):37413\u201320.","journal-title":"J Biol Chem"},{"issue":"14","key":"3951_CR28","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/emboj\/cdf366","volume":"21","author":"L Yu","year":"2002","unstructured":"Yu L, H\u00e9bert MC, Zhang YE. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002;21(14):3749\u201359.","journal-title":"EMBO J"},{"issue":"2","key":"3951_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","volume":"66","author":"R Roskoski Jr.","year":"2012","unstructured":"Roskoski R Jr. ERK1\/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105\u201343.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3951_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10010001","volume":"10","author":"J Cicenas","year":"2017","unstructured":"Cicenas J, et al. JNK, p38, ERK, and SGK1 inhibitors in cancer. Cancers (Basel). 2017;10(1):1.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"3951_CR31","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation. 2007;116(12):1413\u201323.","journal-title":"Circulation"},{"issue":"6","key":"3951_CR32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/jcb.22498","volume":"109","author":"CC Yeh","year":"2010","unstructured":"Yeh CC, et al. Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse. J Cell Biochem. 2010;109(6):1185\u201391.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3951_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1871529X23666230503123612","volume":"23","author":"BA Marzoog","year":"2023","unstructured":"Marzoog BA. Autophagy behavior in postmyocardial infarction injury. Cardiovasc Hematol Disord Drug Targets. 2023;23(1):2\u201310.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"7","key":"3951_CR34","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15990","volume":"12","author":"TC Yeh","year":"2024","unstructured":"Yeh TC. Dapagliflozin prevents ERK activation and SGLT2-dependent endoglin upregulation in a mechanically provoked cardiac injury model. Physiol Rep. 2024;12(7):e15990.","journal-title":"Physiol Rep"},{"issue":"5","key":"3951_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/ajh\/hpz016","volume":"32","author":"L Shi","year":"2019","unstructured":"Shi L, et al. Dapagliflozin attenuates cardiac remodeling in mice model of cardiac pressure overload. Am J Hypertens. 2019;32(5):452\u20139.","journal-title":"Am J Hypertens"},{"key":"3951_CR36","doi-asserted-by":"crossref","unstructured":"Hsieh PL, et al. Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation. Int J Mol Sci. 2022;23(17):10146.","DOI":"10.3390\/ijms231710146"},{"issue":"2","key":"3951_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","volume":"117","author":"D Kolijn","year":"2021","unstructured":"Kolijn D, et al. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation. Cardiovasc Res. 2021;117(2):495\u2013507.","journal-title":"Cardiovasc Res"},{"issue":"16","key":"3951_CR38","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1111\/jcmm.16601","volume":"25","author":"J Tian","year":"2021","unstructured":"Tian J, et al. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats. J Cell Mol Med. 2021;25(16):7642\u201359.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"3951_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04998-z","volume":"80","author":"BH Zhao","year":"2023","unstructured":"Zhao BH, et al. The role and mechanisms of microvascular damage in the ischemic myocardium. Cell Mol Life Sci. 2023;80(11):341.","journal-title":"Cell Mol Life Sci"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-03951-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:43:10Z","timestamp":1783377790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-03951-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3951"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-03951-y","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted by the Animal Ethics Committee of Hefei Gaoxin Cardiovascular Disease Hospital (Approval No. SYDL-2023-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}